Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical KD7040 for Postherpetic Neuralgia
NCT00576108Phase 2Completed
- Sponsor
- Kalypsys, Inc.
- Start
- Nov 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing KD7040 topical gel with Placebo gel (2 arms). Primary endpoint: Worst daily pain. Started Nov 2007; status: completed.
02
Drugs
KD7040
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00576108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576108.